High Grade Glioma: Clinical Trials

98 trials for High Grade Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 recruiting, 30 completed, 15 terminated, 7 active not recruiting. 34 Phase 1, 32 Phase 2, 15 Not applicable, 12 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 134Recruiting 12, Completed 9, Terminated 7, Active not recruiting 3, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 232Recruiting 11, Completed 9, Terminated 7, Not yet recruiting 3, Active not recruiting 1, Withdrawn 1
Not applicable15Completed 8, Recruiting 5, Unknown 1, Withdrawn 1
Early Phase 112Recruiting 5, Terminated 3, Active not recruiting 2, Completed 1, Withdrawn 1
Phase 41Recruiting 1

Follow High Grade Glioma: new trials by email Literature Review of High Grade Glioma trials Research Report on High Grade Glioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma
Dexbrompheniramine, Temozolomide - High Grade Glioma, Glioblastoma
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska412027-06-012026-10-05
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
Opdualag - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2Not yet recruitingNationwide Children's Hospital122027-03-012026-09-09
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Tovorafenib - High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV)
Phase 2Not yet recruitingNationwide Children's Hospital792027-02-012026-10-20
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
NEO100 - Pediatric Tumor of CNS, Pediatric Tumor of Brain
Phase 1RecruitingNeonc Technologies, Inc.122026-09-082026-09-15
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
LMP744, Conventional Surgery or Biopsy - Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Phase 1 / Phase 2RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)402026-07-152026-10-16
A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma
NRG-103 - HGG, High Grade Glioma (III or IV)
Phase 1RecruitingNeuregen Therapeutics Co., Ltd.242026-07-092026-07-17
Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
DNX-2401 - High Grade Glioma, Ependymoma
Phase 2RecruitingClinica Universidad de Navarra, Universidad de Navarra392026-05-122026-05-27
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Entrectinib, Cyclophosphamide, Etoposide - High Grade Glioma, CNS Tumor
Phase 2RecruitingSt. Jude Children's Research Hospital522026-05-012026-11-03
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Nivolumab, Nivolumab-IRDye800 - Brain Cancer, HGG
Early Phase 1RecruitingEben Rosenthal382026-03-272026-07-01
Use of Fluorescence in Gliomas
data collection - High Grade Glioma, Glioblastoma
CompletedAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria412025-09-152026-03-30
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Biological G207 - Neoplasms, High Grade Glioma
Phase 2WithdrawnPediatric Brain Tumor Consortium2025-09-012026-02-10
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2 - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Early Phase 1RecruitingNationwide Children's Hospital152025-08-032026-06-29
STARLITE for Unresectable High-Grade Gliomas
Magnetic Resonance (MR)-guided Laser Interstitial Thermal Therapy (LITT), Abacavir, Lamivudine - High Grade Glioma
Phase 1RecruitingUniversity of Miami242025-04-152026-06-25
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Trametinib and Nivolumab, Dabrafenib, trametinib, nivolumab - Low Grade Glioma, High Grade Glioma
Phase 1 / Phase 2RecruitingAnn & Robert H Lurie Children's Hospital of Chicago272025-04-012026-07-10
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
NK cells - High Grade Glioma
Phase 1RecruitingNationwide Children's Hospital182025-03-042025-05-13
Study of Olutasidenib and Temozolomide in HGG
Olutasidenib + TMZ - High Grade Glioma, Astrocytoma
Phase 2RecruitingRigel Pharmaceuticals602025-02-012026-09-01
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
DB107-RRV, DB107-FC, Radiation Therapy (RT) - High Grade Glioma, MGMT-Unmethylated Glioblastoma
Phase 1 / Phase 2RecruitingUniversity of California, San Francisco702025-01-082026-03-11
A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
Nivolumab, Radiation - High Grade Glioma, Replication Repair Deficient
Not applicableRecruitingDaniel Morgenstern202024-12-062025-08-29
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ribociclib, Everolimus, Temozolomide (TMZ) - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2RecruitingNationwide Children's Hospital1202024-08-222026-05-29
18F-Fluciclovine PET-MRI in High-grade Glioma
18F-Fluciclovine PET-MRI - Glioma, High Grade Glioma
Early Phase 1RecruitingChildren's Hospital of Philadelphia302024-08-072025-12-04

Showing 20 of 98. Sign in to see all of them.

Narrower conditions

Glioma (98)  ·  Glioblastoma (39)  ·  Brain Neoplasms (28)  ·  Astrocytoma (18)  ·  Diffuse Intrinsic Pontine Glioma (17)  ·  Central Nervous System Neoplasms (7)  ·  Neoplasms (7)  ·  Ependymoma (4)  ·  Medulloblastoma (4)  ·  Recurrence (4)  ·  Gliosarcoma (3)  ·  Melanoma (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Oligodendroglioma (3)  ·  Carcinoma, Non-Small-Cell Lung (2)

Broader conditions

Neoplasms, Glandular and Epithelial (98)  ·  Neoplasms by Histologic Type (97)  ·  Neoplasms, Nerve Tissue (97)  ·  Neoplasms, Neuroepithelial (97)  ·  Neuroectodermal Tumors (97)  ·  Neoplasms, Germ Cell and Embryonal (95)  ·  Neoplasms (91)  ·  Neoplasms by Site (44)  ·  Nervous System Diseases (42)  ·  Nervous System Neoplasms (42)  ·  Brain Diseases (40)  ·  Central Nervous System Diseases (40)  ·  Central Nervous System Neoplasms (35)  ·  Astrocytoma (24)  ·  Infratentorial Neoplasms (18)

Interventions

Temozolomide (14)  ·  Radiotherapy (9)  ·  Nivolumab (6)  ·  Blood Specimen Collection (3)  ·  Everolimus (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  ribociclib (3)  ·  Aminolevulinic Acid (2)  ·  Blood Component Removal (2)  ·  Congresses as Topic (2)  ·  Diphtheria-Tetanus Vaccine (2)  ·  Flucytosine (2)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (2)  ·  Imiquimod (2)  ·  Leukapheresis (2)

Sponsors

Nationwide Children's Hospital (10)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (5)  ·  National Cancer Institute (NCI) (3)  ·  Case Comprehensive Cancer Center (2)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  Nader Sanai (2)  ·  Northwell Health (2)  ·  St. Jude Children's Research Hospital (2)  ·  University of California, San Francisco (2)  ·  University of Florida (2)  ·  Alberta Health services (1)  ·  Alpheus Medical, Inc. (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Ashish Shah (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (65)  ·  Canada (11)  ·  Germany (8)  ·  Netherlands (8)  ·  Australia (7)  ·  Italy (7)  ·  China (5)  ·  France (5)  ·  New Zealand (5)  ·  United Kingdom (5)  ·  Spain (4)  ·  Japan (3)  ·  Austria (2)  ·  Belgium (2)  ·  Brazil (2)

Top investigators

Maryam Fouladi, MD (7)  ·  Margot Lazow, MD (4)  ·  Nader Sanai, MD (3)  ·  Stuart A Grossman, MD (3)  ·  Ashish Shah, MD (2)  ·  Elias Sayour, MD, PhD (2)  ·  Jennifer Yu, MD, PhD (2)  ·  John Boockvar, MD (2)  ·  Macarena De La Fuente, MD (2)  ·  Nicholas Butowski, MD (2)  ·  Susan Chi, MD (2)  ·  Albert Murtha, MD (1)  ·  Alberto Valarezo Chuchuca, MD (1)  ·  Alireza Mansouri, MD MSc FRCSC (1)  ·  Andrew Brenner, MD, (1)

Results publications

PMID 41213248, PMID 26843484, PMID 27098749, PMID 29412784, PMID 29763623, PMID 30819765, PMID 31399142, PMID 31419298, PMID 32354716, PMID 32603316, PMID 33034839, PMID 33859944, PMID 34025640, PMID 34101090, PMID 35412366, PMID 35791008, PMID 38049523, PMID 38503417, PMID 38537315, PMID 38771986, PMID 38968568, PMID 40025673, PMID 40225909, PMID 40875628, PMID 41218853, PMID 41296829, PMID 41544350

NIH funding

2018 (2), UM1CA137443 (2), 2017 (1), 2023 (1), P30CA012197 (1), R01CA195563 (1), R21CA186140 (1), R21CA282543 (1), U01CA062475 (1), UM1CA081457 (1)